43 results on '"Calvo, Mariona"'
Search Results
2. Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma
3. Mevrometostat (PF-06821497), an enhancer of zeste homolog 2 (EZH2) inhibitor, in combination with enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC): A randomized dose-expansion study.
4. Assessing the impact of COVID-19 on liver cancer management (CERO-19)
5. External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
6. Endoscopic biliary drainage in unresectable biliary obstruction: the role of endoscopic ultrasound-guidance in a cohort study
7. Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience
8. Successful closure of a refractory gastrobronchial fistula using endoscopic mucosal ablation followed by single loop-and-clips technique
9. Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
10. Interim analysis of the ACTION trial: Cabozantinib for hepatocellular carcinoma patients who discontinued first line treatment other than sorafenib or due to sorafenib intolerance
11. Dissecting the role of the NADPH Oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma
12. A multi-center, open-label, randomized dose expansion study of PF-06821497, a potent and selective inhibitor of enhancer of zeste homolog 2 (EZH2), in patients with metastatic castration-resistant prostate cancer (mCRPC).
13. Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours
14. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series
15. COMBINACIÓN DE DISECCIÓN + OTSC Y ABLACIÓN APC + LOOP-AND-CLIP (KING CLOSURE) PARA CIERRE DE FÍSTULA REBELDE GASTRO-BRONQUIAL
16. Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
17. Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first‐line platinum‐based chemotherapy: Phase 2 study results.
18. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients
19. Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series.
20. En comunitat, utilitza la creativitat! Compartim els projectes de treball comunitari: fira de projectes
21. Prótesis esofágicas de diseño específico para uso cervical y con liberación proximal: experiencia acumulada en centro terciario
22. The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
23. PARALLEL 303: Phase 2 randomized study of pamiparib vs placebo as maintenance therapy in patients (pts) with inoperable locally advanced or metastatic gastric cancer that responded to platinum-based first-line (1L) chemotherapy.
24. MONEO: A phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC).
25. THU-124 - Interim analysis of the ACTION trial: Cabozantinib for hepatocellular carcinoma patients who discontinued first line treatment other than sorafenib or due to sorafenib intolerance
26. External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
27. Clinical significance of peritoneal molecular markers in patients with locally advanced gastric cancer (LAGC) without macroscopic peritoneal implants treated with perioperative chemotherapy (ChT).
28. PRÓTESIS DE APOSICIÓN LUMINAL EN EL DRENAJE BILIAR DE PATOLOGÍA BILIOPANCREÁTICA MALIGNA IRRESECABLE: EXPERIENCIA EN CENTRO TERCIARIO
29. A fresh look at polymicrobial bloodstream infection in cancer patients
30. Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre
31. Radical chemoradiotherapy for patients with locally advanced esophageal cancer. Long-term follow up of an ambispective study
32. Clinical Features, Etiology, and Outcome of Bacteremic Pneumonia in Cancer Patients.
33. Neoadjuvant treatment in borderline resectable pancreatic adenocarcinoma (pa): a single center serie.
34. P-059 - Radical chemoradiotherapy for patients with locally advanced esophageal cancer. Long-term follow up of an ambispective study
35. Clinical outcomes in phase 1 clinical trials (Ph1-CT) when treating patients (pts) with novel immunotherapy (IT) agents at early lines for advanced disease.
36. Treatment of complete esophageal stenosis using endoscopic ultrasound-guided puncture: a novel technique for access to the distal lumen
37. Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients
38. The Role of Her2 in Locally Advanced Resectable Gastric Cancer as a Prognostic and Predictive Factor
39. Impact of multidisciplinary cancer care on the postoperative mortality and survival of patients with esophageal and esophagogastric junction cancer.
40. P-0061 Docetaxel Monotherapy as a Second-Line Salvage Treatment in Advanced Gastric Cancer: Experience of 40 Patients with Prognostic Factor Analysis
41. P-0051 Prognostic Factors Correlated to Poor Outcome Among Patients with Potentially Curable Gastric Cancer Treated with Perioperative Chemotherapy
42. P-0075 - The Role of Her2 in Locally Advanced Resectable Gastric Cancer as a Prognostic and Predictive Factor
43. Correction: Successful closure of a refractory gastrobronchial fistula using endoscopic mucosal ablation followed by single loop-and-clips technique.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.